headerhome

Opening New Frontiers By Advancing The Promise of PI Signaling Pathways

Petra News

Share

3 December 2018

Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting

item11

x

timelinearrowleft

timelinearrowright